Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

China flag China · Delayed Price · Currency is CNY
11.73
+0.62 (5.58%)
Apr 1, 2025, 2:45 PM CST
40.48%
Market Cap 15.58B
Revenue (ttm) 5.26B
Net Income (ttm) 646.74M
Shares Out 1.47B
EPS (ttm) 0.44
PE Ratio 26.59
Forward PE 23.44
Dividend n/a
Ex-Dividend Date n/a
Volume 10,118,539
Average Volume 5,110,230
Open 11.61
Previous Close 11.11
Day's Range 11.06 - 11.85
52-Week Range 8.10 - 12.54
Beta 0.57
RSI 61.69
Earnings Date Mar 29, 2025

About SHE:002399

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium A... [Read more]

Sector Healthcare
Founded 1998
Employees 2,080
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002399
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.